It's all about who's buying cannabis products.
News & Analysis: Neptune Wellness Solutions
NEPT earnings call for the period ending December 31, 2019.
A new bill introduced in the House would reclassify cannibidiol as a dietary supplement.
The stocks are more reasonably priced and trading at better valuations, but could they fall even further?
The Food and Drug Administration's consumer update on cannabidiol might appear damning, but investors can still profit from CBD's growth.
Extraction-service providers appeared safe from near-term marijuana growing pains, but this isn't the case any longer.
Neptune Wellness has not delivered strong financial results, but it’s too early to strike this company from your list.
NEPT earnings call for the period ending September 30, 2019.
Whereas most pot stocks are losing money, this niche industry became profitable almost from the get-go.
Yes, it is possible to minimize your investing risk while having exposure to the fast-growing cannabis industry.